Dr. Korman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UH Cleveland Medical Center
11100 Euclid Ave Department of Dermatology
Cleveland, OH 44106Phone+1 216-844-8200Fax+1 216-844-3964- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterResidency, Dermatology, 1987 - 1990
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Dermatology, 1985 - 1987- Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 1984 - 1985
Case Western Reserve University School of MedicineClass of 1984
Case Western Reserve UniversityPh.D., Biomedical Engineering, 1977 - 1982- State University of New YorkM.S., Mechanical Engineering, 1976 - 1977
- State University of New YorkB.E., Engineering Science, with High Honors, 1973 - 1977
- Queens CollegeNo Degree, 1972 - 1973
Certifications & Licensure
OH State Medical License 1985 - 2024
MD State Medical License 1987 - 1990- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Best Doctor US News and World Report, 2011
- Teacher of the Year, Dept. of Dermatology University Hospitals of Cleveland, 1993
- Join now to see all
Clinical Trials
- Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris Start of enrollment: 1996 Nov 01
- Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01
- Use of KC706 for the Treatment of Pemphigus Vulgaris Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast.Emma L Larson, Dustin P DeMeo, Andrew B Young, Seunghee Margevicius, Joseph Rutter, Amanda L Davies, Craig A Rohan, Neil J Korman, Jeffrey B Travers, Thomas S McCormic...> ;The Journal of Investigative Dermatology. 2024 Feb 29
- The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.Shah, M., Crowley, J., Gordon, K., Shahriari, M., Burshtein, J., Zakria, D., Lockshin, B., Merola, J., Korman, N., Chovatiya, R., Kalb, R., Lebwohl, M.> ;Dermatology and Therapy. 2024 Feb 1
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2.Susan Taylor, Neil J Korman, Tsen-Fang Tsai, Yutaka Shimomura, Meghan Feely, Yves Dutronc, Wen-Shuo Wu, Najwa Somani, Antonella Tosti> ;Dermatology and Therapy. 2023 Dec 1
- Join now to see all
Journal Articles
- Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study throu...Langley RG, Lebwohl M, Krueger GG, Szapary PO, Wasfi Y, Chan D, Hsu MC, You Y, Poulin Y, Korman NJ, Prinz JC, Reich K, Br J Dermatol, 1/1/2015
- Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of expertsMurrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP,..., J Am Acad Dermatol, 1/1/2015
- Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe plaque psoriasis: 52-week results of a phase 3, randomised, controlled trial (ES...Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RGB, Hu CC, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CEM, J Am Acad Dermatol, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell LymphomaNeil Korman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Does nutrition affect the severity of psoriasis?Churton SE, Debanne S, McCormick TS, Cooper KD, Korman NJ, J Invest Dermatol, 1/1/2015
- Autosomal Dominant Transgradient Palmoplantar Keratoderma (PPK) and Hypotrichosis Treated Adequately with 13-Cis Retinoic Acid and Acitretin: a novel kindred and reass...Cohn HI, Korman NJ, J Invest Dermatol, 1/1/2015
- Join now to see all
Lectures
- Autoimmune Blistering Diseases: What's NewAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- Advanced Systemic TherapiesColorado Springs, CO - 1/1/2015
- Autoimmune Blistering Diseases - Approach to Diagnosis and ManagementColorado Springs, CO - 1/1/2015
- Join now to see all
Press Mentions
Safety and Efficacy of IL-17 Blockers for Psoriatic ArthritisNovember 22nd, 2022- Preventing the Onset of PsA in Patients with PsoriasisMay 5th, 2022
- Cardiovascular Risk in Patients with PsoriasisApril 14th, 2022
- Join now to see all
Grant Support
- Translational Research CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2010
- Epidermal Bullous Pemphigoid AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–1998
- Feasibility Study--Cytokines And Chemical Skin CarcinogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994
- Characterization Of Epidermal Bullous Pemphigoid AntigenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1991
Professional Memberships
- Fellow
Hospital Affiliations
University Hospitals Cleveland Medical CenterCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
